FUM
NEUTRALFutura Medical Appoints New Broker
The healthcare company has appointed a new broker to act as its sole broker and continue as Nominated Adviser.
Futura Medical
8.69GBX
1.52%
Market Cap
26.96M
Volume
831.54k
165% of avg
P/E Ratio
0.04
EPS (TTM)
2.18
Beta
0.99
Day Range
8.30p - 9.00p
52 Week Range
8.30p8.69p45.56p
8.69p
Upcoming Events
End of 2025
Regulatory approval for Eroxon® Intense expected in EU & USA
High Impact Event
Early Q2 2026
Completion of Early Feasibility Study for WSD4000
FUM
BADFutura Medical Reports First Profit, But Warns of Slower Growth Ahead
The healthcare company reported its maiden profit and significant revenue growth, but warned of slower expansion and launch delays, impacting future performance expectations.
FUM
NEUTRALFutura Medical Announces Results and Investor Presentation
The healthcare company will announce its annual results and host investor presentations next month.
FUM
NEUTRALFutura Medical Appoints New Non-Executive Director
The healthcare company has appointed a new Non-executive Director with investment management experience.
FUM
BADFutura Medical Slashes FY25 Forecast Despite Strong FY24 Performance
The healthcare company reported strong FY24 results but drastically lowered FY25 expectations due to slower product adoption. A shift from anticipated profits to projected losses in FY25 has overshadowed the positive performance.
FUM
NEUTRALFutura Medical Announces Positive Results for Women's Sexual Dysfunction Treatment
The healthcare company reports successful completion of a study for its women's sexual dysfunction treatment, paving the way for further development.
FUM
NEUTRALFutura Medical Announces Non-Executive Director Remuneration
Pharmaceutical company Futura Medical announces routine update on Non-Executive Director remuneration.
FUM
NEUTRALLombard Odier Increases Stake in Futura Medical
Modest increase in stake by institutional investor in this healthcare company.
FUM
NEUTRALFutura Medical Sees Minor Shift in Major Shareholder
Biotechnology company Futura Medical sees minor shift in major shareholder position
FUM
NEUTRALFutura Medical Announces Encouraging New Product Pipeline
The healthcare company announces successful proof of concept studies for two new sexual health products, expanding its pipeline.